Prognostic Factors, Predictive Modeling, and Treatment Patterns in Breast Cancer Patients with Bone Metastasis Receiving First-Line Chemotherapy: A Population-Based Study
Annali Italiani di Chirurgia · 2024
DOI: 10.62713/aic.3807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annali Italiani di Chirurgia, 2024. Verfasst von Xin Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Orthopedics Department, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 321000 Jinhua, Zhejiang, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Bone Neoplasms, Nomograms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
AIM: The prognostic factors and a nomogram applicable to breast cancer (BC) patients with bone metastasis (BM) who received first-line chemotherapy have not been extensively studied. This study aimed to identify prognostic factors and construct a prognostic nomogram to predict overall survival (OS) in this population. METHODS: Data for BC patients with BM undergoing first-line chemotherapy were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2016. A total of 2996 BC patients with BM undergoing first-line chemotherapy were included. Age, tumor size, race, tumor grade, breast cancer subtype, brain metastasis, liver metastasis, lung metastasis, surgical intervention, and marital status were identified as independent prognostic factors in the training cohort. Patients were randomly assigned into a training cohort (n = 2100) and an internal validation cohort (n = 896). Prognostic variables were identified using univariate and multivariate Cox Proportional Hazards (Cox) regression analysis. A nomogram was constructed and validated in both cohorts. The discrimination and accuracy of the nomogram were evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). RESULTS: The areas under the curves (AUCs) for 1-, 2- and 3-year OS were 0.803 (95% confidence interval (CI): 0.752–0.854), 0.785 (95% CI: 0.756–0.814), and 0.767 (95% CI: 0.701–0.803), respectively, in the training cohort, and 0.793 (95% CI: 0.756–0.830), 0.791 (95% CI: 0.761–0.821), and 0.756 (95% CI: 0.719–0.793), respectively, in the validation cohort. The nomogram demonstrated excellent discrimination, calibration, and clinical utility. CONCLUSIONS: This study developed and validated a robust survival prediction model for breast cancer patients with bone metastasis receiving first-line chemotherapy. The nomogram demonstrates strong predictive performance and can aid clinicians in formulating individualized treatment strategies, thereby improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Orthopedics Department, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 321000 Jinhua, Zhejiang, China.
Zitieren
APA
Fu, X., Cai, P., Yan, Z., Xu, K., Zhao, W., & Wang, J. (2024). Prognostic Factors, Predictive Modeling, and Treatment Patterns in Breast Cancer Patients with Bone Metastasis Receiving First-Line Chemotherapy: A Population-Based Study. Annali Italiani di Chirurgia. https://doi.org/10.62713/aic.3807
Vancouver
Fu X, Cai P, Yan Z, Xu K, Zhao W, Wang J. Prognostic Factors, Predictive Modeling, and Treatment Patterns in Breast Cancer Patients with Bone Metastasis Receiving First-Line Chemotherapy: A Population-Based Study. Annali Italiani di Chirurgia. 2024. doi:10.62713/aic.3807
BibTeX
@article{Fu2024,
author = {Fu, Xin and Cai, Pengfei and Yan, Zhengqiang and Xu, Kangshuai and Zhao, Wei and Wang, Jinhua},
title = {Prognostic Factors, Predictive Modeling, and Treatment Patterns in Breast Cancer Patients with Bone Metastasis Receiving First-Line Chemotherapy: A Population-Based Study},
journal = {Annali Italiani di Chirurgia},
year = {2024},
doi = {10.62713/aic.3807}
}
EUVIMED